Analysts made two notable upgrades this week. INTC and ED both received fresh Buy-equivalent calls, lifting consensus sentiment on each.
Intel's upgrade is a bold call. The chipmaker has struggled for years. Its market cap sits at $547 billion. Yet the consensus Buy count now stands at 5 — up from 4. The average target price is $84.43. That implies significant upside from current levels.
Consolidated Edison also moved higher. Analysts upgraded the utility. The consensus now shows 6 Buy ratings versus 7 Holds. The average target stands at $111.19.
On the other side, PFE got a small target price lift. Average targets edged up to $29.19. Pfizer's long recovery from post-COVID weakness continues to attract cautious optimism.
AEE and EFX both saw target prices trimmed. Ameren's average target slipped to $119.87. Equifax fell to $227.52.
FICO also had its target nudged down to $1,560. Still, the stock commands 15 Buys against just 1 Sell.
DDOG picked up a fresh new recommendation. The cloud monitoring firm now has 45 Buy ratings — among the strongest consensus reads in software.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
